Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 164


Nanomedicine-based formulations containing ω-3 polyunsaturated fatty acids: potential application in cardiovascular and neoplastic diseases.

Serini S, Cassano R, Trombino S, Calviello G.

Int J Nanomedicine. 2019 Apr 23;14:2809-2828. doi: 10.2147/IJN.S197499. eCollection 2019. Review.


Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system.

Darwesh AM, Sosnowski DK, Lee TY, Keshavarz-Bahaghighat H, Seubert JM.

Chem Biol Interact. 2019 Aug 1;308:20-44. doi: 10.1016/j.cbi.2019.04.037. Epub 2019 May 5. Review.


The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease.

Nelson JR, Raskin S.

Postgrad Med. 2019 May;131(4):268-277. doi: 10.1080/00325481.2019.1607414. Epub 2019 May 7. Review.


Dietary total fat, fatty acids intake, and risk of cardiovascular disease: a dose-response meta-analysis of cohort studies.

Zhu Y, Bo Y, Liu Y.

Lipids Health Dis. 2019 Apr 6;18(1):91. doi: 10.1186/s12944-019-1035-2. Review.


Advances in n-3 polyunsaturated fatty acid nutrition.

Li D, Wahlqvist ML, Sinclair AJ.

Asia Pac J Clin Nutr. 2019;28(1):1-5. doi: 10.6133/apjcn.201903_28(1).0001. Review.


New Areas of Interest: Is There a Role for Omega-3 Fatty Acid Supplementation in Patients With Diabetes and Cardiovascular Disease?

Welty FK.

Curr Diab Rep. 2019 Jan 25;19(2):6. doi: 10.1007/s11892-019-1126-5. Review.


Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, AlAbdulghafoor FK, Summerbell CD, Worthington HV, Song F, Hooper L.

Cochrane Database Syst Rev. 2018 Nov 30;11:CD003177. doi: 10.1002/14651858.CD003177.pub4.


Benefits of multiple micronutrient supplementation in heart failure: A comprehensive review.

Dragan S, Buleu F, Christodorescu R, Cobzariu F, Iurciuc S, Velimirovici D, Xiao J, Luca CT.

Crit Rev Food Sci Nutr. 2019;59(6):965-981. doi: 10.1080/10408398.2018.1540398. Epub 2018 Dec 3. Review.


The Role of Omega-3 Fatty Acids in the Setting of Coronary Artery Disease and COPD: A Review.

Pizzini A, Lunger L, Sonnweber T, Weiss G, Tancevski I.

Nutrients. 2018 Dec 2;10(12). pii: E1864. doi: 10.3390/nu10121864. Review.


Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease.

Tam KW, Wu MY, Siddiqui FJ, Chan ES, Zhu Y, Jafar TH.

Cochrane Database Syst Rev. 2018 Nov 18;11:CD011353. doi: 10.1002/14651858.CD011353.pub2.


Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies.

Singh NK, Rao GN.

Prog Lipid Res. 2019 Jan;73:28-45. doi: 10.1016/j.plipres.2018.11.001. Epub 2018 Nov 22. Review.


Effects of fatty and lean fish intake on stroke risk: a meta-analysis of prospective cohort studies.

Qin ZZ, Xu JY, Chen GC, Ma YX, Qin LQ.

Lipids Health Dis. 2018 Nov 23;17(1):264. doi: 10.1186/s12944-018-0897-z.


Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.


Pro-resolving lipid mediators: Agents of anti-ageing?

Doyle R, Sadlier DM, Godson C.

Semin Immunol. 2018 Dec;40:36-48. doi: 10.1016/j.smim.2018.09.002. Epub 2018 Oct 4. Review.


Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids.

Adili R, Hawley M, Holinstat M.

Prostaglandins Other Lipid Mediat. 2018 Nov;139:10-18. doi: 10.1016/j.prostaglandins.2018.09.005. Epub 2018 Sep 25. Review.


Omega-3 PUFA attenuate mice myocardial infarction injury by emerging a protective eicosanoid pattern.

Fang X, Cai W, Cheng Q, Ai D, Wang X, Hammock BD, Zhu Y, Zhang X.

Prostaglandins Other Lipid Mediat. 2018 Nov;139:1-9. doi: 10.1016/j.prostaglandins.2018.09.002. Epub 2018 Sep 14. Review.


Pro-resolving lipid mediators in vascular disease.

Conte MS, Desai TA, Wu B, Schaller M, Werlin E.

J Clin Invest. 2018 Aug 31;128(9):3727-3735. doi: 10.1172/JCI97947. Epub 2018 Aug 31. Review.


Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.

Nicholls SJ, Lincoff AM, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, Koenig W, McGuire DK, Mozaffarian D, Pedersen TR, Ridker PM, Ray K, Karlson BW, Lundström T, Wolski K, Nissen SE.

Clin Cardiol. 2018 Oct;41(10):1281-1288. doi: 10.1002/clc.23055. Epub 2018 Sep 28. Review.


Dietary n-6 polyunsaturated fatty acids and cardiovascular disease: Epidemiologic evidence.

Wang DD.

Prostaglandins Leukot Essent Fatty Acids. 2018 Aug;135:5-9. doi: 10.1016/j.plefa.2018.05.003. Epub 2018 May 29. Review.


Supplemental Content

Loading ...
Support Center